一个实用的方法来管理穿皮冠状动脉干预并发症的管理
Tanawat Attachaipanich1, Hafeez Ul Hassan Virk2, Muzamil Khawaja3
1Department of Internal Medicine, University of Missouri-Kansas City School of Medicine, Kansas City, MO, United States.
Frontiers in cardiovascular medicine
|February 23, 2026
概括
尽管取得了进展,穿皮冠状动脉干预 (PCI) 的并发症仍然存在. 了解风险和预防是改善复杂PCI程序结果的关键.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
背景情况:
- 尽管在支架设计,药物治疗和技术方面取得了进展,但穿皮冠状动脉干预 (PCI) 的并发症仍然存在.
- 复杂的PCI程序越来越多,带来更高的不良事件风险.
- 优化程序结果需要了解风险因素,机制,管理和预防.
研究的目的:
- 审查目前关于PCI相关并发症的证据.
- 识别管理和预防PCI并发症的知识差距.
主要方法:
- 一个叙事审查,利用一个专注的PubMed搜索到2025年10月.
- 随机试验,大型观察性研究,指导方针和共识陈述的优先考虑.
主要成果:
- 急性血管闭塞 (切割,血栓,穿孔) 可能导致血液动力学损害和死亡.
- 与设备相关的罕见并发症 (陷入,骨折) 构成重大风险.
- 预防包括病变的准备,设备的选择,温和的操纵和成像;管理依赖于有限的证据.
结论:
- 早期识别和及时管理对于减少PCI不利结果至关重要.
- 未来的大规模研究,注册表数据和人工智能引导的建模是个性化的预测和增强程序安全的必要条件.
相关概念视频
Acute Coronary Syndrome IV: Interprofessional Care
332
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
332
Angina IV: Management
347
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
347
Coronary Artery Disease V: Interprofessional Care
324
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
324
Peripheral Artery Disease III: Interprofessional Care
403
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
403
Cardiac Catheterization IV: Nursing Management
863
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
863
Pericarditis III: Medical Management
415
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
415


